Henry Park, MD, MPH

Dr. Henry S. Park is a board-certified radiation oncologist who serves as professor, vice chair for clinical research, chief of thoracic radiotherapy, and chief of PET-guided radiotherapy for the Department of Therapeutic Radiology at the Yale School of Medicine. For the Yale Cancer Center, he is an assistant medical director of the Clinical Trials Office, where he also leads the radiation oncology committee and is associate leader of the lung clinical research team. Dr. Park subspecializes in radiation therapy for cancers of the lung and the head and neck. He leads a wide-ranging research program in clinical trials, real-world evidence, novel radiotherapy technology, and health services. He has co-authored over 200 peer-reviewed original research articles, reviews, book chapters, invited editorials, and practice guidelines. He serves as an oral and written boards examiner for the American Board of Radiology, an associate editor for Advances in Radiation Oncology and American Journal of Clinical Oncology, and an active committee member for the American Society for Radiation Oncology, American Radium Society, SWOG, and NRG. He has been honored with multiple awards for his contributions to patient care, clinical research, medical education, and journal peer reviewing.

Disclosures:

• Employment: Yale School of Medicine:Associate Professor, Vice Chair for Clinical Research:Employee;Yale School of Medicine:Assistant Professor:Employee
• Compensation: Galera Therapeutics, Inc.: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: 10/1/21 ;AstraZeneca: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Education Meeting Faculty, Honoraria-End Date: to present ;Bristol Myers Squibb: Education Meeting Faculty, Honoraria-End Date: 4/1/21 ;RefleXion Medical: Consultant, Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Honoraria-End Date: to present ;G1 The
• Ownership: none
• Leadership: none